• Pharma
  • April 1, 2021
  • 7 views
Parameters for evaluating FDCs should be changed: IDMA

The Sub-committee of Drugs Technical and Advisory Board (DTAB) is examining the fixed-dose combinations (FDCs) which are considered irrational by Prof Kokate Committee. The committee has asked the concerned applicants to…